{"id":"5daaedb2-f61b-444d-ae08-2b97d6c03972","kind":"institutions","code":"UB-I9200","name":"Guanzi Venture Capital","nameBasis":"transliterated","summary":"关子创投 is a venture capital investor based in China (mainland) with 1 recorded investment.","description":"","country":null,"category":null,"originalName":"关子创投","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T15:46:30.928Z","englishUpdatedAt":"2026-10-15T17:35:39.086Z","reviewedAt":"2026-10-15T17:35:39.086Z","snapshotAt":"2026-10-15T16:06:35.585Z","sourceHash":"72b92026860c5e3173a92150733198053dc63644308c68872d9684bc2320215b","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"","sources":[],"related":[{"id":"50c02dc6-b605-4206-b59b-257bb6b7b197","kind":"news","code":"50c02dc6-b605-4206-b59b-257bb6b7b197","name":"iRegene completes equity financing","nameBasis":"translated-title","summary":"On 2026-03-30, according to Xiniu Data, iRegene completed equity financing for an undisclosed amount. Investors were Beijiguang Venture Capital, Guanzi Venture Capital, Hehui Biotechnology.","description":"","country":null,"category":null,"originalName":"睿健医药完成股权投资融资","eventDate":"2026-03-30T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T12:46:27.321Z","englishUpdatedAt":"2026-10-15T20:50:22.045Z","reviewedAt":"2026-10-15T20:50:22.045Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"da7c75afb316bd70d46c3ffffe9c2489773e9cb9b6a2637ff8439373becf485d","companyId":"c6f40f74-5248-4720-8404-fd1e03022e90","foundedYear":null,"logoUrl":null,"path":"/news/50c02dc6-b605-4206-b59b-257bb6b7b197"}],"path":"/institutions/guanzi-venture-capital","displayName":"关子创投","displayNameLang":"zh","structured":{"city":null,"country":"China (mainland)","location":null,"role":null,"category":null,"company":null},"definition":"关子创投 is a venture capital investor based in China (mainland) with 1 recorded investment.","summaryBasis":"generated","thin":false,"canonical":"https://uniquebase.ai/institutions/guanzi-venture-capital"}